Topics

Primary Sclerosing Cholangitis Pipeline Review, H2 2019 [Published by Global Markets Direct] Prices from USD $1760

07:53 EST 4 Dec 2019 | BioPortfolio Report Blog

Primary Sclerosing Cholangitis Pipeline Review, H2 2019


Summary


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Primary Sclerosing Cholangitis Pipeline Review, H2 2019, provides an overview of the Primary Sclerosing Cholangitis Gastrointestinal pipeline landscape.


Primary sclerosing cholangitis PSC is a chronic liver disease characterized by a progressive course of cholestasis with inflammation and fibrosis of the intrahepatic and extra hepatic bile ducts. Symptoms include abdominal pain, chills, diarrhea, fatigue, itchiness and weight loss. The predisposing factors include age and inflammatory bowel diseases. Treatment includes antibiotics and bileacidbinding drugs.


Report Highlights


Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Primary Sclerosing Cholangitis Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Primary Sclerosing Cholangitis Gastrointestinal, complete with analysis by stage of development, drug target, mechanism of action MoA, route of administration RoA and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.


The Primary Sclerosing Cholangitis Gastrointestinal pipeline guide also reviews of key players involved in therapeutic development for Primary Sclerosing Cholangitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 2, 7, 4, 1, 11 and 1 respectively.


Primary Sclerosing Cholangitis Gastrointestinal pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industryspecific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.


Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.


Scope


The pipeline guide provides a snapshot of the global therapeutic landscape of Primary Sclerosing Cholangitis Gastrointestinal.

The pipeline guide reviews pipeline therapeutics for Primary Sclerosing Cholangitis Gastrointestinal by companies and universities/research institutes based on information derived from company and industryspecific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from preregistration till discovery and undisclosed stages.

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, RD brief, MoA other developmental activities.

The pipeline guide reviews key companies involved in Primary Sclerosing Cholangitis Gastrointestinal therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Primary Sclerosing Cholangitis Gastrointestinal therapeutics based on mechanism of action MoA, drug target, route of administration RoA and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

The pipeline guide reviews latest news related to pipeline therapeutics for Primary Sclerosing Cholangitis Gastrointestinal


Reasons to buy


Procure strategically important competitor information, analysis, and insights to formulate effective RD strategies.

Recognize emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage.

Find and recognize significant and varied types of therapeutics under development for Primary Sclerosing Cholangitis Gastrointestinal.

Classify potential new clients or partners in the target demographic.

Develop tactical initiatives by understanding the focus areas of leading companies.

Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

Formulate corrective measures for pipeline projects by understanding Primary Sclerosing Cholangitis Gastrointestinal pipeline depth and focus of Indication therapeutics.

Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the knowhow what drove them from pipeline.

Original Article: Primary Sclerosing Cholangitis Pipeline Review, H2 2019 [Published by Global Markets Direct] Prices from USD $1760

NEXT ARTICLE

More From BioPortfolio on "Primary Sclerosing Cholangitis Pipeline Review, H2 2019 [Published by Global Markets Direct] Prices from USD $1760"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Hepatology
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...

Pain
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...